Product Name :
KA2507
Description:
KA2507 is a potent and selective HDAC6 inhibitor, with an IC50 of 2.5 nM. KA2507 shows antitumor activities and immune modulatory effects in preclinical models.
CAS:
1636894-46-6
Molecular Weight:
322.32
Formula:
C16H14N6O2
Chemical Name:
4-{[bis(pyrazin-2-yl)amino]methyl}-N-hydroxybenzamide
Smiles :
ONC(=O)C1C=CC(CN(C2=CN=CC=N2)C2=CN=CC=N2)=CC=1
InChiKey:
LXHMTDHBMRZSHJ-UHFFFAOYSA-N
InChi :
InChI=1S/C16H14N6O2/c23-16(21-24)13-3-1-12(2-4-13)11-22(14-9-17-5-7-19-14)15-10-18-6-8-20-15/h1-10,24H,11H2,(H,21,23)
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.{{Carmofur} MedChemExpress|{Carmofur} Neuronal Signaling|{Carmofur} Activator|{Carmofur} Purity & Documentation|{Carmofur} In stock|{Carmofur} custom synthesis}
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
KA2507 is a potent and selective HDAC6 inhibitor, with an IC50 of 2.5 nM. KA2507 shows antitumor activities and immune modulatory effects in preclinical models.|Product information|CAS Number: 1636894-46-6|Molecular Weight: 322.32|Formula: C16H14N6O2|Chemical Name: 4-{[bis(pyrazin-2-yl)amino]methyl}-N-hydroxybenzamide|Smiles: ONC(=O)C1C=CC(CN(C2=CN=CC=N2)C2=CN=CC=N2)=CC=1|InChiKey: LXHMTDHBMRZSHJ-UHFFFAOYSA-N|InChi: InChI=1S/C16H14N6O2/c23-16(21-24)13-3-1-12(2-4-13)11-22(14-9-17-5-7-19-14)15-10-18-6-8-20-15/h1-10,24H,11H2,(H,21,23)|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Solubility: DMSO : 66.{{Roxadustat} web|{Roxadustat} Apoptosis|{Roxadustat} Technical Information|{Roxadustat} Formula|{Roxadustat} manufacturer|{Roxadustat} Autophagy} 67 mg/mL (206.PMID:24282960 84 mM; Need ultrasonic).|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vitro:|KA2507 did not inhibit the in vitro proliferation of mouse or human cancer cells at concentrations that are selective for HDAC6 inhibition.|In Vivo:|KA2507 (100-200 mg/kg; p.o.; daily; for 20 days) inhibits tumor growth in the syngeneic B16-F10 mouse melanoma model. KA2507 also demonstrates antitumor efficacy in CT26 and MC38 colorectal cancer models. Analysis of tumor samples also indicates modulation of biomarkers of antitumor immunity at efficacious dosing, with KA2507 administration resulting in reduced STAT3 activation (as measured by phospho-STAT3, an important suppressor of the antitumor immune response), reduced PD-L1 expression, and increased expression of MHC class I. KA2507 exhibits poor oral bioavailability (mice 15%) and Cmax (mice 300 ng/mL) following oral administration (mice 200 mg/kg).|Products are for research use only. Not for human use.|